{"pageContent": "Background: In vitro data and early clinical results suggest that metformin has desirable antineoplastic effects and has a theoretical benefit on castration-resistant prostate cancer (CRPC).", "metaData": {"source": "Localised prostate cancer: treatment versus surveillance?\nhttps://pubmed.ncbi.nlm.nih.gov/16598883/"}}